retatrutide latest news ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide Achieves Large Weight Decreases

This would impact some of the 45.8 million adults under 65 with private insurance, in both individual and employer plans, who are clinically eligible for these drugs and are obese

Rather than targeting GLP-1 receptors alone, it's a dual agonist activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously

Interestingly, several alterations in intra-pancreatic actions of GIP have been found in subjects affected by T2DM

Steve Small: Yeah, good thoughts there

Rao often recommends the Lilly Direct program, which allows patients to purchase medications directly from the company at a discounted rate, along with coupon codes and patient assistance programs